Outcomes in children with nasolacrimal duct obstruction: Significance of persistent symptoms while stents are in place.
To evaluate the correlation between persistent symptoms while stents are in place and final outcome in children with nasolacrimal duct obstruction (NLDO). A retrospective observational case series, with medical record review that included indications for surgery, surgical procedure, presence of symptoms while stents were in place, and final outcome after stent removal. Twenty-eight children with NLDO had nasolacrimal duct stents placed in 42 eyes. Twenty-one of the 42 eyes (50%) had minimal or no signs or symptoms of NLDO while stents were in place, and 18 of 21 (86%) were symptom-free after stent removal. Twenty-one of the 42 eyes (50%) remained symptomatic while stents were in place. Eleven of these 21 eyes (52%) had good outcomes after stent removal. Ten (48%) of these patients had persistent symptoms after stent removal requiring further treatment. The prognosis for a good outcome is excellent if symptoms of NLDO resolve while stents are in place. The prognosis is poorer if symptoms of NLDO persist, but more than half of such patients still have good outcomes. Careful counseling of parents regarding these outcomes should be performed before considering additional interventions.
Espinoza
Gabriela M
GM
Department of Ophthalmology and Visual Sciences, St. Louis Children's Hospital at Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Lueder
Gregg T
GT
D002648:Child; D002675:Child, Preschool; D004129:Dimethylpolysiloxanes; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007440:Intubation; D007767:Lacrimal Duct Obstruction / Q000151:congenital / Q000175:diagnosis* / Q000628:therapy*; D009301:Nasolacrimal Duct; D011379:Prognosis; D012189:Retrospective Studies; D012828:Silicones; D015607:Stents; D013997:Time Factors
D004129:Dimethylpolysiloxanes; D012828:Silicones; C013830:baysilon